| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 87 |
| 1 | PREDNISONE | 79 |
| 2 | ADALIMUMAB | 73 |
| 3 | ACETAMINOPHEN | 56 |
| 4 | TACROLIMUS | 53 |
| 5 | TIRZEPATIDE | 52 |
| 6 | GEMCITABINE HYDROCHLORIDE | 51 |
| 7 | OCTREOTIDE ACETATE | 48 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 45 |
| 9 | TACROLIMUS OINTMENT 0.1% | 45 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOXIDECTIN | 1 | 0.3333 |
| 1 | RED GINSENG | 1 | 0.1250 |
| 2 | CAMIZESTRANT | 1 | 0.0714 |
| 3 | TRICLABENDAZOLE | 1 | 0.0227 |
| 4 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 5 | AMMONIA N-13 | 1 | 0.0175 |
| 6 | AMMONIA | 1 | 0.0114 |
| 7 | GABA (GAMMA-AMINOBUTYRIC ACID) | 2 | 0.0093 |
| 8 | RILZABRUTINIB | 4 | 0.0071 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 2 | 0.0056 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 39 | 0.0018 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 4 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 5 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 6 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 8 | Methylating Agent [EPC] | 1 | 0.0010 |
| 9 | GLP-2 Analog [EPC] | 12 | 0.0009 |